Pictet Asset Management (Switzerland)’s Charles River Laboratories CRL Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4.15M	Sell	19,741 -256	-1%	-$50.9K	﹤0.01%	800
2023 Q1	$4.04M	Buy	19,997 +500	+3%	+$113K	0.01%	823
2022 Q4	$4.25M	Sell	19,497 -1,505	-7%	-$329K	0.01%	775
2022 Q3	$4.13M	Buy	21,002 +358	+2%	+$77.3K	0.01%	773
2022 Q2	$4.42M	Hold	20,644	–	–	0.01%	785
2022 Q1	$5.86M	Buy	20,644 +446	+2%	+$138K	0.01%	781
2021 Q4	$7.61M	Sell	20,198 -119	-0.6%	-$46.2K	0.01%	742
2021 Q3	$8.38M	Buy	+20,317	New	+$8.44M	0.01%	716

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CRL Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Charles River Laboratories (CRL) stake by 1.3% in Q2 2023, selling an estimated $50.9K and leaving 19,741 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Pictet Asset Management (Switzerland) first reported a position in CRL in Q3 2021 and has held it in 8 quarters since. The position peaked at $8.38M in Q3 2021. 613 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

Pictet Asset Management (Switzerland) held 19,741 shares of Charles River Laboratories worth $4.15M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 256 Charles River Laboratories shares in Q2 2023, an estimated $50.9K.
Charles River Laboratories made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #800 holding.
Pictet Asset Management (Switzerland) first reported a position in Charles River Laboratories in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Charles River Laboratories position peaked at $8.38M in Q3 2021.
613 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.